AG
BSTC

Algert Global’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Algert Global’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,834
Closed -$364K – 370
2017
Q3 		$364K Sell
7,834
-90
-1% -$4.31K 0.08% 250
2017
Q2 		$392K Hold
7,924
– – 0.11% 228
2017
Q1 		$434K Buy
7,924
+410
+5% +$21.7K 0.12% 241
2016
Q4 		$419K Buy
+7,514
New +$361K 0.12% 247

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Algert Global's BSTC Position: Q4 2017 in Review

Algert Global sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2017, closing a stake of 7,834 shares — an estimated $364K sold.

Algert Global first reported a position in BSTC in Q4 2016 and held it in 4 quarters. The position peaked at $434K in Q1 2017. 88 funds tracked by Wall St. Rank hold BSTC as of Q4 2017.

  • Algert Global reported no remaining BioSpecifics Technologies Corp. position as of Q4 2017 after selling out during the quarter.
  • Algert Global sold 7,834 BioSpecifics Technologies Corp. shares in Q4 2017, an estimated $364K.
  • Algert Global first reported a position in BioSpecifics Technologies Corp. in Q4 2016 and held it in 4 quarters.
  • Algert Global's BioSpecifics Technologies Corp. position peaked at $434K in Q1 2017.
  • 88 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2017.

Based on Algert Global's 13F filing for Q4 2017, filed 1 Feb 2018.